Tirzepatide: A Review in Type 2 Diabetes Nicole L. FranceYahiya Y. Syed Adis Drug Evaluation 23 February 2024 Pages: 227 - 238
Vonoprazan: A Review in Helicobacter pylori Infection Matt Shirley Adis Drug Evaluation Open access 23 February 2024 Pages: 319 - 327
Correction: New Pharmacologic Approaches to the Treatment of Bipolar Depression Kamyar KeramatianTrisha ChakrabartyLakshmi N. Yatham Correction 12 February 2024 Pages: 369 - 369
Methadone for Cancer Pain Management in Children: A Review of Literature Sebastiano Mercadante Review Article 07 February 2024 Pages: 203 - 208
Long-Term Efficacy and Tolerability of PCSK9 Targeted Therapy: A Review of the Literature Willemijn A. M. SchonckErik S. G. StroesLaurens F. Reeskamp Review Article Open access 25 January 2024 Pages: 165 - 178
Chinese Herbal Medicines for Coronary Heart Disease: Clinical Evidence, Pharmacological Mechanisms, and the Interaction with Gut Microbiota Linhai CaoHongxia NiHui Chang Review Article 24 January 2024 Pages: 179 - 202
Correction to: Nedosiran: First Approval Yahiya Y. Syed Correction Open access 22 January 2024 Pages: 255 - 255
Lumasiran: A Review in Primary Hyperoxaluria Type 1 Connie Kang Adis Drug Evaluation Open access 22 January 2024 Pages: 219 - 226
Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry Jonathan SchimmelLindsey Claire Eppersonthe Toxicology Investigators Consortium FACT Study Group Original Research Article 10 January 2024 Pages: 209 - 217
Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges Camille AllardDaniela CotaCarmelo Quarta Review Article 21 December 2023 Pages: 127 - 148
Spesolimab for the Treatment of Generalized Pustular Psoriasis Diana BernardoDiamant ThaçiTiago Torres Review Article Open access 20 December 2023 Pages: 45 - 58
Reply to the Comments on “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study” Thomas Yen-Ting ChenQianru ZhangJames Cheng-Chung Wei Letter to the Editor 18 December 2023 Pages: 123 - 125
Comment on “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study” Wen-Bin YehWei-Kai LeeCheuk-Kwan Sun Letter to the Editor 18 December 2023 Pages: 121 - 122
Comment on: “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study” Tsung-Wei ChangCheng-Hsien Hung Letter to the Editor 18 December 2023 Pages: 119 - 120
Targeting KRAS-Mutated Gastrointestinal Malignancies with Small-Molecule Inhibitors: A New Generation of Breakthrough Therapies Bennett A. CaugheyJohn H. Strickler Review Article 18 December 2023 Pages: 27 - 44
Pharmacological Treatments of Temporomandibular Disorders: A Systematic Review Including a Network Meta-Analysis Nikolaos ChristidisEssam Ahmed Al-MoraissiMalin Collin Systematic Review Open access 16 December 2023 Pages: 59 - 81
Zilucoplan: First Approval Matt Shirley AdisInsight Report Open access 14 December 2023 Pages: 99 - 104
New Therapies on the Horizon for Primary Biliary Cholangitis Atsushi Tanaka Leading Article 12 December 2023 Pages: 1 - 15
Gepirone Extended-Release: First Approval Susan J. Keam AdisInsight Report 11 December 2023 Pages: 1723 - 1728
HIV Pre-Exposure Prophylaxis: New and Upcoming Drugs to Address the HIV Epidemic Christina G. RiveraJohn D. ZeuliZelalem Temesgen Review Article 11 December 2023 Pages: 1677 - 1698
Correction to: Motixafortide: First Approval Sheridan M. Hoy Correction 07 December 2023 Pages: 1737 - 1737
Nedosiran: First Approval Yahiya Y. Syed AdisInsight Report Open access 07 December 2023 Pages: 1729 - 1733
Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension John P. BerdahlSteven R. Sarkisian Jrthe Travoprost Intraocular Implant Study Group Original Research Article Open access 07 December 2023 Pages: 83 - 97
Waldenström Macroglobulinemia: Targeted Agents Taking Center Stage Shayna SarosiekJorge J. Castillo Review Article 06 December 2023 Pages: 17 - 25
Correction: Elacestrant: First Approval Sheridan M. Hoy Correction Open access 25 November 2023 Pages: 1735 - 1735
Mitapivat: A Review in Pyruvate Kinase Deficiency in Adults Amy Zhuang-YanMatt Shirley Adis Drug Evaluation 22 November 2023 Pages: 1613 - 1620
Aetiology of Significant Liver Test Abnormalities in a Single-Centre Cohort of People with Cystic Fibrosis Exposed to Elexacaftor/Tezacaftor/Ivacaftor, Utilizing the Updated RUCAM Daniel TewkesburyAndrew M. JonesPeter J. Barry Original Research Article 15 November 2023 Pages: 1699 - 1707
Current and Emerging Treatment Options for Uterine Fibroids Mohamed AliMichał CiebieraAyman Al-Hendy Review Article 03 November 2023 Pages: 1649 - 1675
Correction to: Lotilaner Ophthalmic Solution 0.25%: First Approval Yahiya Y. Syed Correction Open access 31 October 2023 Pages: 1543 - 1543
Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis Francesco BonellaPaolo SpagnoloChris Ryerson Leading Article Open access 26 October 2023 Pages: 1581 - 1593
Correction to: Rozanolixizumab: First Approval Sheridan M. Hoy Correction Open access 20 October 2023 Pages: 1569 - 1569
Lotilaner Ophthalmic Solution 0.25%: First Approval Yahiya Y. Syed AdisInsight Report Open access 16 October 2023 Pages: 1537 - 1541
Current Medical Therapy for Adenomyosis: From Bench to Bedside Andrea EtruscoFabio BarraAntonio Simone Laganà Review Article Open access 14 October 2023 Pages: 1595 - 1611
The Place of Cannabinoids in the Treatment of Gynecological Pain Justin SinclairJason AbbottMike Armour Current Opinion Open access 13 October 2023 Pages: 1571 - 1579
Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review Robert Terkeltaub Review Article 11 October 2023 Pages: 1501 - 1521
Correction to: Ritlecitinib: First Approval Hannah A. Blair Correction Open access 05 October 2023 Pages: 1457 - 1457
